Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.2865
Abstract: Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML). In this phase 2 study, we treated 18‐ to 65‐year‐old AML patients refractory to first‐line 3 + 7 daunorubicin/cytarabine induction or relapsing after 3 + 7… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5916
Abstract: Though the efficacy of anti C‐type lectin‐like molecule‐1 (CLL1) CAR T‐cells in refractory/relapsed acute myeloid leukemia (R/R‐AML) have been occasionally reported, the influence of co‐stimulatory domain CAR T‐cells is not investigated so far. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Annals of Hematology"
DOI: 10.1007/s00277-018-3454-y
Abstract: Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for high-risk myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal prognosis and further therapeutic options are limited. One potential curative… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Leukemia"
DOI: 10.1038/s41375-024-02474-6
Abstract: Relapsed Acute Lymphoblastic Leukemia (ALL) is among the most common causes of cancer-associated deaths in children. However, little is known about the implications of deviations from ALL treatment protocols on survival rates. The present study… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-019-0690-2
Abstract: Optimization of the salvage regimen is required to improve prognosis in primary refractory or relapsed acute myeloid leukemia (AML). In fit patients, a bridge to allogeneic transplant is the primary purpose of salvage. We tested… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Investigative Medicine High Impact Case Reports"
DOI: 10.1177/2324709617690747
Abstract: Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-119909
Abstract: INTRODUCTION Acute leukemia relapsing after allogeneic stem cell transplantation (AlloSCT) is usually associated with dismal prognosis. Treatment options in this population remain limited. We evaluated the outcomes of second AlloSCT in patients with acute leukemia… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Annals of Clinical Microbiology and Antimicrobials"
DOI: 10.1186/s12941-017-0240-y
Abstract: BackgroundBotulism is a potentially fatal infection characterized by progressive muscle weakness, bulbar paralysis, constipation and other autonomic dysfunctions. A recent report suggested that cancer chemotherapy might increase the risk for the intestinal toxemia botulism in… read more here.